Melita A. Gordon

Melita A. Gordon

Auto-generated profile, based on publicly available information

Melita A. Gordon

Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
PDF file
JCJohn A. Crump
John A. Crump
MSMaria Sjölund-Karlsson
Maria Sjölund-Karlsson
MGMelita A. Gordon
Melita A. Gordon
CPChristopher M. Parry
Christopher M. Parry
SUMMARY Salmonella enterica infections are common causes of bloodstream infection in low-resource areas, where they may be difficult to distinguish from other febrile illnesses and may be associated with a high case fatality ratio. Microbiologic culture of blood or bone marrow remains the mainstay of laboratory diagnosis. Antimicrobial resistance has emerged in Salmonella enterica, initially to the traditional first-line drugs chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole. Decreased fluoroquinolone susceptibility and then fluoroquinolone resistance have developed in association with chromosomal mutations in the quinolone resistance-determining region of genes encoding DNA gyrase and topoisomerase IV and also by plasmid-mediated resistance mechanisms. Resistance to extended-spectrum cephalosporins has occurred more often in nontyphoidal than in typhoidal Salmonella strains. Azithromycin is effective for the management of uncomplicated typhoid fever and may serve as an alternative oral drug in areas where fluoroquinolone resistance is common. In 2013, CLSI lowered the ciprofloxacin susceptibility breakpoints to account for accumulating clinical, microbiologic, and pharmacokinetic-pharmacodynamic data suggesting that revision was needed for contemporary invasive Salmonella infections. Newly established CLSI guidelines for azithromycin and Salmonella enterica serovar Typhi were published in CLSI document M100 in 2015.

1 June 2012 in The Lancet
Verified
Journal Article
Open access
NFNicholas A Feasey
Nicholas A Feasey
GDGordon Dougan
Gordon Dougan
RKRobert Kingsley
Robert Kingsley
RHRobert S Heyderman
Robert S Heyderman
MGMelita A Gordon
Melita A Gordon
Invasive strains of non-typhoidal salmonellae have emerged as a prominent cause of bloodstream infection in African adults and children, with an associated case fatality of 20-25%. The clinical presentation of invasive non-typhoidal salmonella disease in Africa is diverse: fever, hepatosplenomegaly, and respiratory symptoms are common, and features of enterocolitis are often absent. The most important risk factors are HIV infection in adults, and malaria, HIV, and malnutrition in children. A distinct genotype of Salmonella enterica var Typhimurium, ST313, has emerged as a new pathogenic clade in sub-Saharan Africa, and might have adapted to cause invasive disease in human beings. Multidrug-resistant ST313 has caused epidemics in several African countries, and has driven the use of expensive antimicrobial drugs in the poorest health services in the world. Studies of systemic cellular and humoral immune responses in adults infected with HIV have revealed key host immune defects contributing to invasive non-typhoidal salmonella disease. This emerging pathogen might therefore have adapted to occupy an ecological and immunological niche provided by HIV, malaria, and malnutrition in Africa. A good understanding of the epidemiology of this neglected disease will open new avenues for development and implementation of vaccine and public health strategies to prevent infections and interrupt transmission.

9 November 2009 in Genome Research
Verified
Journal Article
Open access
PDF file
RKRobert Kingsley
Robert Kingsley
CMChisomo Lawrence Msefula
Chisomo Lawrence Msefula
NTNicholas R. Thomson
Nicholas R. Thomson
SKSamuel Kariuki
Samuel Kariuki
KHKathryn E. Holt
Kathryn E. Holt
GDGordon Dougan
Gordon Dougan
Whereas most nontyphoidal Salmonella (NTS) are associated with gastroenteritis, there has been a dramatic increase in reports of NTS-associated invasive disease in sub-Saharan Africa. Salmonella enterica serovar Typhimurium isolates are responsible for a significant proportion of the reported invasive NTS in this region. Multilocus sequence analysis of invasive S. Typhimurium from Malawi and Kenya identified a dominant type, designated ST313, which currently is rarely reported outside of Africa. Whole-genome sequencing of a multiple drug resistant (MDR) ST313 NTS isolate, D23580, identified a distinct prophage repertoire and a composite genetic element encoding MDR genes located on a virulence-associated plasmid. Further, there was evidence of genome degradation, including pseudogene formation and chromosomal deletions, when compared with other S. Typhimurium genome sequences. Some of this genome degradation involved genes previously implicated in virulence of S. Typhimurium or genes for which the orthologs in S. Typhi are either pseudogenes or are absent. Genome analysis of other epidemic ST313 isolates from Malawi and Kenya provided evidence for microevolution and clonal replacement in the field.

23 March 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MRManuela Raffatellu
Manuela Raffatellu
Renato De Lima SantosRenato De Lima Santos
Renato De Lima Santos
DVDavid E Verhoeven
David E Verhoeven
MGMichael D George
Michael D George
RWR Paul Wilson
R Paul Wilson
ABAndreas J Bäumler
Andreas J Bäumler

1 June 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
TATrong T. Ao
Trong T. Ao
NFNicholas A. Feasey
Nicholas A. Feasey
MGMelita A. Gordon
Melita A. Gordon
KKKaren Helena Keddy
Karen Helena Keddy
FAFrederick J. Angulo
Frederick J. Angulo
JCJohn A. Crump
John A. Crump
Nontyphoidal Salmonella is a major cause of bloodstream infections worldwide, and HIV-infected persons and malaria-infected children are at increased risk for the disease. We conducted a systematic literature review to obtain age group–specific, population-based invasive nontyphoidal Salmonella (iNTS) incidence data. Data were categorized by HIV and malaria prevalence and then extrapolated by using 2010 population data. The case-fatality ratio (CFR) was determined by expert opinion consensus. We estimated that 3.4 (range 2.1–6.5) million cases of iNTS disease occur annually (overall incidence 49 cases [range 30–94] per 100,000 population). Africa, where infants, young children, and young adults are most affected, has the highest incidence (227 cases [range 152–341] per 100,000 population) and number of cases (1.9 [range 1.3–2.9] million cases). An iNTS CFR of 20% yielded 681,316 (range 415,164–1,301,520) deaths annually. iNTS disease is a major cause of illness and death globally, particularly in Africa. Improved understanding of the epidemiology of iNTS is needed.

11 May 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VWVanessa K Wong
Vanessa K Wong
SBStephen Baker
Stephen Baker
DPDerek J Pickard
Derek J Pickard
JPJulian Parkhill
Julian Parkhill
APAndrew Page
Andrew Page
GDGordon Dougan
Gordon Dougan